Get the Stockscreener App
34.44
0.29%
0.10
Pre-market:
34.56
0.12
+0.35%
Astrana Health Inc stock is traded at $34.44, with a volume of 389.72K.
It is up +0.29% in the last 24 hours and down -9.63% over the past month.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
See More
Previous Close:
$34.34
Open:
$34.32
24h Volume:
389.72K
Relative Volume:
0.69
Market Cap:
$1.71B
Revenue:
$3.53B
Net Income/Loss:
$30.99M
P/E Ratio:
56.15
EPS:
0.6134
Net Cash Flow:
$154.99M
1W Performance:
+0.41%
1M Performance:
-9.63%
6M Performance:
+43.38%
1Y Performance:
+22.65%
1-Day Range:
$33.54
$34.53
1-Week Range:
$32.22
$35.52
52-Week Range:
$18.08
$51.60
Astrana Health Inc Stock (ASTH) Company Profile
Name
Astrana Health Inc
Sector
Industry
Phone
(626) 282-0288
Address
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, EHC, FMS, DVA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASTH
Astrana Health Inc
|
34.44 | 1.71B | 3.53B | 30.99M | 154.99M | 0.6134 |
HCA
Hca Healthcare Inc
|
423.48 | 91.68B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
249.54 | 20.09B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
122.01 | 12.04B | 6.07B | 793.80M | 464.40M | 5.9914 |
FMS
Fresenius Medical Care Ag Adr
|
22.35 | 11.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
DVA
Davita Inc
|
174.67 | 11.14B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-25 | Initiated | Needham | Buy |
| Apr-01-25 | Initiated | Barclays | Equal Weight |
| Oct-14-24 | Initiated | TD Cowen | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-11-24 | Upgrade | Truist | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Feb-26-24 | Initiated | Jefferies | Buy |
| Feb-22-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-24 | Initiated | Stifel | Buy |
| Dec-22-23 | Initiated | Truist | Hold |
| Oct-17-23 | Initiated | BTIG Research | Buy |
| Apr-12-23 | Initiated | BofA Securities | Neutral |
| Dec-19-22 | Initiated | Lake Street | Buy |
| Sep-21-22 | Initiated | William Blair | Outperform |
| Jan-11-22 | Resumed | Colliers Securities | Buy |
| Aug-12-21 | Initiated | Barclays | Equal Weight |
View All
Astrana Health Inc Stock (ASTH) Latest News
Astrana Health faces securities fraud probe aft... - Pluang
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH - PR Newswire
Apollo Medical Holdings Inc (3AM.MU) Stock Price, News, Quote & History - ca.finance.yahoo.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Astrana Healt - natlawreview.com
Astrana buys Prospect's managed care arm for $708M out of bankruptcy - Dealroom
Astrana Health, Inc. (ASTH) Stock Price, News, Quote & History - ca.finance.yahoo.com
Astrana Health Inc. (ASTH) Stock Forecasts - finance.yahoo.com
Astrana Health, Inc. (ASTH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Why Astrana Health (ASTH) Shares Are Trading Lower Today - finance.yahoo.com
Astrana Health Q3 Results: Sales guide $1.000B-$1.030B vs $1.021B est - scanx.trade
Astrana Health FY26 Results: Sales guidance affirmed at $3.800B-$4.100B - scanx.trade
Astrana Health, Inc. - Reuters
Astrana Health Reports Material Cyberattack; Shares Fall Pre-Bell - marketscreener.com
Astrana is latest U.S. healthcare company to face acyberattack - TradingView
Astrana Health (ASTH) Stock May Be Fully Priced As Shares Fell 67% - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Lowey Dannenberg, P.C. is Investigating Astrana Health, - GlobeNewswire
Astrana Health Inc. (ASTH) Stock Analysis: A Promising 54% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Lowey Dannenberg probes Astrana Health after short-seller report - scanx.trade
M&A AwardsDEAL OF THE YEAR$500 MILLION – $1 BILLION HONOREE: Astrana Health acquires Prospect Medical Holdings - Los Angeles Business Journal
Astrana Health: Strong Execution, Still No Re-Rating (NASDAQ:ASTH) - Seeking Alpha
A Look at Astrana Health Inc (ASTH) After 9.0% Decline -- GF Val - GuruFocus
Astrana Health stock tumbles after short report - Investing.com
Astrana Health stock tumbles after short report By Investing.com - Investing.com Canada
Astrana Health Shares Fall After GlassHouse Research Publishes Short-Seller Report - Moomoo
Astrana Health falls amid short call from GlassHouse Research - TradingView
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know - Yahoo Finance
Form 8K Astrana Health Inc For: 15 September By Investing.com - Investing.com India
Astrana Health updates corporate presentation, reiterates FY2026 guidance and $267.5M adj. EBITDA midpoint - TradingView
Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53 - Moomoo
Oppenheimer Initiates Astrana Health at Outperform With $53 Price Target - marketscreener.com
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down - The Globe and Mail
ETFs Investing in Astrana Health Inc. Stocks - TradingView
Astrana Health CEO Brandon Sim Surrenders Shares to Cover Tax Withholding on RSU Vesting - Kalkine Media
Enterprise value to revenue forward of Astrana Health Inc. – NASDAQ:ASTH - TradingView
Astrana Health (ASTH) exec surrenders shares to cover RSU taxes - Stock Titan
Here’s What Boosted Astrana Health (ASTH) in Q2 - Yahoo Finance
Astrana Health (ASTH) director sells 8,500 shares back to the company at $37.09 - Stock Titan
Astrana (ASTH) Momentum: Posts a 3.15% Loss to $38.11 on the Day; Chart View: Traders Can Monitor the $36.20-$40.02 Range in Latest TradingMomentum Surge Alerts - careplusvn.com
Astrana (ASTH) Range: Moves 1.57% Higher to $39.35 in the Current Update; Boundary Watch - siam.in
Astrana Health (ASTH) Shares Just Moved, So What Is Going On? - Sahm
Astrana Health Director David Schmidt Executes Option Exercise and Sells Shares via Issuer Repurchase - Kalkine Media
Astrana Health (NASDAQ: ASTH) director sells 20K shares back to company - Stock Titan
ASTH | Astrana Health Inc. Common FinancialsRevenue Breakdown - quiverquant.com
Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Surges 7.99% to $40.81 — Key Levels to WatchHigh Beta Stocks - Vinanet
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call - Yahoo Finance
Astrana Health Inc (ASTH) Shares Surge 8.2% -- What GF Score of 85 Tells Investors - GuruFocus
Astrana Health (NASDAQ:ASTH) Rally Puts Growth In Focus - Kalkine Media
Astrana Health Jumps 7.1% After Truist Securities Maintains Buy - AlphaStreet
Astrana Health (ASTH) Surges 7.57% as Healthcare Services Stock Breaks HigherLow Risk Entry Stocks - Vinanet
Astrana Health Inc Stock (ASTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.32%
1.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):